Table 2. Correlation of BRAF mutation detection between IHC and molecular assays.
BRAF molecular assays | ||||
---|---|---|---|---|
positive | negative | Total | ||
IHC | positive | 148 | 2 | 150 (43%) |
negative | 0 | 199 | 199 (57%) | |
Total | 148 (42%) | 201 (58%) | 349 (100%) |
IHC, immunohistochemistry; BRAF molecular assays using Sanger sequencing and Cobas 4800 BRAF V600 Mutation Test.